Johnson Pharmacare has accepted the resignation of Ms. Neha Srivastava as Company Secretary and Compliance Officer, effective June 11, 2026. The company confirmed that the resignation was submitted due to personal reasons and that there are no other material reasons for the departure.

The disclosure was made to the Bombay Stock Exchange on June 12, 2026, in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The resignation was tendered by Ms. Srivastava in a letter addressed to the Board of Directors.

Ms. Srivastava requested that the necessary forms and intimations be filed with the Registrar of Companies and other statutory authorities to give effect to her resignation. She expressed gratitude for the opportunity to serve the company and thanked the Board and management for their support during her tenure.

The following table summarizes the key details of the change:

The filing was signed by Dheeraj Kumar, Additional Director, on behalf of the Board of Directors of Johnson Pharmacare Limited.

Johnson Pharmacare Limited reported a net loss of ₹5,573.39 lakh for the financial year ended March 31, 2026, significantly widening from a net loss of ₹58.38 lakh in the previous year. The company's total income for FY26 stood at ₹158.10 lakh, while total expenses surged to ₹4,304.49 lakh, primarily driven by other expenses amounting to ₹4,276.48 lakh. The board approved the audited financial results for the quarter and year ended March 31, 2026, during a meeting held on May 27, 2026.

The standalone financial statements were subject to a qualified opinion from the statutory auditor, VRSK & Associates, due to non-provision of interest on loans and non-compliance with Indian Accounting Standards (Ind AS). The auditor noted that the company is not capable of meeting its liabilities as and when they fall due within a period of one year from the balance sheet date. Additionally, the company reported cash losses of ₹11,123.52 lakh for the current financial year.

Financial Performance

The company recorded a basic and diluted earnings per share (EPS) of (₹1.01) for FY26, a significant decline from (₹0.01) in the previous year. The balance sheet reflects total assets of ₹2,203.11 lakh as of March 31, 2026, a decrease from ₹5,792.59 lakh in the prior year. Non-current investments stood at ₹1,972.50 lakh, while borrowings amounted to ₹2,140.19 lakh.

Board and Governance Updates

During the meeting, the board took note of the resignations of two directors effective April 17, 2026. Rajendra Prasad, Additional Non-Executive Director, and Umesh Kumar, Additional Executive Director, both resigned citing personal reasons and unavoidable circumstances. The board also confirmed that Regulation 32 of the SEBI (LODR) Regulations, 2015, regarding deviation or variation, is not applicable to the company as it has not issued equity shares via preferential issue.

The trading window, which closed on April 1, 2026, will remain shut until 48 hours after the declaration of the audited financial results. The filing was signed by Nand Kishor Ray, Additional Director, on behalf of the board.